A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)
Каталог · ЕАЭС
Клинические исследования и проекты
Global Alliance for TB Drug Development · найдено 2
2 исследования
Завершено
Фаза III
Россия
Pretomanid; Linezolid; Bedaquiline; Placebo Linezolid · Global Alliance for TB Drug Development
Завершено
Фаза II–III
Россия
Pretomanid; Bedaquiline; Moxifloxacin; Pyrazinamide; HRZE; HR · Global Alliance for TB Drug Development
An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)